Found 5 results

Name Type of Offering Accepted Date
Euclises Pharmaceuticals, Inc. See All Filings
D/A 2015-10-01
Amount To Be Raised $1,851,250
Associated Brokers / Dealers N/A
CIK Number 0001550350
Filed Document 0001550350-15-000001
Exclusions or Exemptions 506b
Accepted Date 2015-10-01
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MISSOURI
Revenue or Assets Decline to Disclose
Type of Security Equity
Euclises Pharmaceuticals, Inc. See All Filings
D 2014-01-09
Amount To Be Raised $1,400,000
Associated Brokers / Dealers N/A
CIK Number 0001550350
Filed Document 0001550350-14-000001
Exclusions or Exemptions 506b
Accepted Date 2014-01-09
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MISSOURI
Revenue or Assets Decline to Disclose
Type of Security Equity
Euclises Pharmaceuticals, Inc. See All Filings
D 2015-10-01
Amount To Be Raised $662,603
Associated Brokers / Dealers N/A
CIK Number 0001550350
Filed Document 0001550350-15-000002
Exclusions or Exemptions 506c
Accepted Date 2015-10-01
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MISSOURI
Revenue or Assets Decline to Disclose
Type of Security Equity
Euclises Pharmaceuticals, Inc. See All Filings
D 2012-05-16
Amount To Be Raised $400,000
Associated Brokers / Dealers N/A
CIK Number 0001550350
Filed Document 0001550350-12-000001
Exclusions or Exemptions N/A
Accepted Date 2012-05-16
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MISSOURI
Revenue or Assets Decline to Disclose
Type of Security Equity
Euclises Pharmaceuticals, Inc. See All Filings
D/A 2016-12-01 15:18:01
Amount To Be Raised $2,711,198
Associated Brokers / Dealers N/A
CIK Number 0001550350
Filed Document 0001550350-16-000003
Exclusions or Exemptions 506c
Accepted Date 2016-12-01 15:18:01
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MISSOURI
Revenue or Assets Decline to Disclose
Type of Security Equity